Isobamate en es it fr

Isobamate Brand names, Isobamate Analogs

Isobamate Brand Names Mixture

  • No information avaliable

Isobamate Chemical_Formula


Isobamate RX_link

Isobamate fda sheet

Isobamate msds (material safety sheet)

Isobamate Synthesis Reference

Berger, Ludwig, U.S. Pat. 2,937,119 (1960)

Isobamate Molecular Weight

260.33 g/mol

Isobamate Melting Point

92-93 oC

Isobamate H2O Solubility

0.3 mg/ml

Isobamate State


Isobamate LogP


Isobamate Dosage Forms


Isobamate Indication

For the relief of discomfort associated with acute, painful, musculoskeletal conditions.

Isobamate Pharmacology

Carisoprodol is used as a skeletal muscle relaxant. One of its metabolites, meprobamate, is available as an anxiolytic agent.

Isobamate Absorption

No information avaliable

Isobamate side effects and Toxicity

Symptoms of overdose include drowsiness, giddiness, nausea, indigestion, or rash. Other adverse effects attributed to therapeutic use of carisoprodol include dizziness, irritability, insomnia, diplopia, temporary loss of vision, ataxia, weakness, headache, and dysarthria. Non-CNS adverse effects include gastrointestinal complaints, tachycardia, and postural hypotension. Patients sensitive to sulfites or tartrazine may experience wheezing, allergic rashes including erythema multiforme, or anaphylaxis after using some preparations of carisoprodol which contain such additives

Isobamate Patient Information

Carisoprodol is a muscle relaxant used to relieve the pain and stiffness of muscle spasms and discomfort due to strain and sprain. Inform your physician if you are pregnant or nursing. Do not take this medication with a monoamine oxidase inhibitor. This medication may cause dizziness, drowsiness, or blurred vision; use caution while driving or operating hazardous machinery. Do not take any other sedating drugs or drink alcohol while taking carisoprodol. If dizziness occurs, avoid sudden changes in posture. Take this medication with food to avoid stomach upset. Notify your physician if you develop trouble breathing, unexplained fever, severe weakness, vision changes, swelling, or skin rash. Withdrawal symptoms may occur if therapy is suddenly stopped in a patient on long-term or high-dose therapy.

Isobamate Organisms Affected

Humans and other mammals